2851 - 2860 of 9104 Results
Title
Year
-
OPENTitle: 17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/969418Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/969418.pdfCitation Count: 12
- From iPS Cells to Rodents and Nonhuman Primates: Filling Gaps in Modeling Parkinson's Disease2020RESTRICTEDTitle: From iPS Cells to Rodents and Nonhuman Primates: Filling Gaps in Modeling Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 832End Page: 841Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28387Citation Count: 16
-
OPENTitle: OFF episode quality of life impact scale (OFFELIA): A new measure of quality of life for off episodes in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 123Issue #:Start Page: 106070End Page: 106070Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106070Best OA location URL: http://www.prd-journal.com/article/S1353802024000828/pdfCitation Count: 3
-
OPENTitle: GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease SusceptibilityJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 3Start Page: 761End Page: 766Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70127Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70127Citation Count: 1
- Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's disease2016RESTRICTEDTitle: Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 19End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.07.005Citation Count: 33
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://www.prd-journal.com/article/S1353802018304310/pdfCitation Count: 18
- Teaching program for the Unified Dyskinesia Rating Scale2009RESTRICTEDTitle: Teaching program for the Unified Dyskinesia Rating ScaleJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 9Start Page: 1296End Page: 1298Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22563Citation Count: 12
-
OPENTitle: Precise disease heterogeneity and progression quantification in MSA and Parkinson’s disease using machine learningJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-026-45949-5Best OA location URL: https://www.nature.com/articles/s41598-026-45949-5_reference.pdfCitation Count: 0
- Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics2005RESTRICTEDTitle: Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinicsJournal Name: Movement DisordersPublisher: WileyVol: 21Issue #: 4Start Page: 519End Page: 23Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.20751Citation Count: 0
- Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's disease2017RESTRICTEDTitle: Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 6Start Page: 893End Page: 903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26976Citation Count: 35